Development of pharmacogenetic biomarkers predicting anti-tuberculous drug-induced adverse drug reactio
Not Applicable
Recruiting
- Conditions
- Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
- Registration Number
- KCT0000591
- Lead Sponsor
- Dankook Univeristy Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Adverse reactions to antituberculosis drugs
- cutaneous reactions
- liver injury: increase in AST, ALT or ALP
Exclusion Criteria
Refused to be enrolled
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of gentic variants
- Secondary Outcome Measures
Name Time Method demographic and clinical parameters such as age and comorbidity